AU2003244437A1 - Quinoxalinones and their use especially in the treatment of cardiovascular diseases - Google Patents
Quinoxalinones and their use especially in the treatment of cardiovascular diseasesInfo
- Publication number
- AU2003244437A1 AU2003244437A1 AU2003244437A AU2003244437A AU2003244437A1 AU 2003244437 A1 AU2003244437 A1 AU 2003244437A1 AU 2003244437 A AU2003244437 A AU 2003244437A AU 2003244437 A AU2003244437 A AU 2003244437A AU 2003244437 A1 AU2003244437 A1 AU 2003244437A1
- Authority
- AU
- Australia
- Prior art keywords
- quinoxalinones
- treatment
- cardiovascular diseases
- use especially
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10205219.0 | 2002-02-08 | ||
| DE10205219A DE10205219A1 (en) | 2002-02-08 | 2002-02-08 | Quinoxalinones and their use |
| PCT/EP2003/000782 WO2003066057A1 (en) | 2002-02-08 | 2003-01-27 | Quinoxalinones and their use especially in the treatment of cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003244437A1 true AU2003244437A1 (en) | 2003-09-02 |
Family
ID=27618445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003244437A Abandoned AU2003244437A1 (en) | 2002-02-08 | 2003-01-27 | Quinoxalinones and their use especially in the treatment of cardiovascular diseases |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1476164B1 (en) |
| AU (1) | AU2003244437A1 (en) |
| CA (1) | CA2475320A1 (en) |
| DE (2) | DE10205219A1 (en) |
| ES (1) | ES2250896T3 (en) |
| WO (1) | WO2003066057A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2404658A (en) * | 2003-08-07 | 2005-02-09 | Bayer Ag | Quinoxalinone derivatives and their use in the treatment of diseases |
| DE10343098A1 (en) * | 2003-09-18 | 2005-04-14 | Bayer Healthcare Ag | Tetrahydroquinoxalines and their use |
| US7601716B2 (en) | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3819444A1 (en) * | 1988-06-08 | 1989-12-14 | Thomae Gmbh Dr K | NEW CONDENSED DIAZEPINONE, PROCESS FOR THEIR MANUFACTURE AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| CZ403592A3 (en) * | 1992-02-20 | 1993-12-15 | Hoechst Ag | Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use |
| DE4341663A1 (en) * | 1993-12-07 | 1995-06-08 | Basf Ag | New bi:cyclic piperazinone carboxamide, carboxylic or sulphonic ester |
-
2002
- 2002-02-08 DE DE10205219A patent/DE10205219A1/en not_active Withdrawn
-
2003
- 2003-01-27 AU AU2003244437A patent/AU2003244437A1/en not_active Abandoned
- 2003-01-27 ES ES03737277T patent/ES2250896T3/en not_active Expired - Lifetime
- 2003-01-27 DE DE50301547T patent/DE50301547D1/en not_active Expired - Fee Related
- 2003-01-27 CA CA002475320A patent/CA2475320A1/en not_active Abandoned
- 2003-01-27 EP EP03737277A patent/EP1476164B1/en not_active Expired - Fee Related
- 2003-01-27 WO PCT/EP2003/000782 patent/WO2003066057A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003066057A1 (en) | 2003-08-14 |
| ES2250896T3 (en) | 2006-04-16 |
| DE10205219A1 (en) | 2003-08-21 |
| CA2475320A1 (en) | 2003-08-14 |
| DE50301547D1 (en) | 2005-12-08 |
| EP1476164A1 (en) | 2004-11-17 |
| EP1476164B1 (en) | 2005-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1068885A1 (en) | N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n-- | |
| AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
| AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
| AU2003206311A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
| AU2003206310A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
| AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
| HK1162948A1 (en) | Hemiasterlin derivatives and uses thereof in the treatment of cancer (hemiasterlin) | |
| AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
| EP1765832B8 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
| AU2003265620A1 (en) | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition | |
| GB0615918D0 (en) | Composition and its therapeutic use | |
| AU2003238242A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
| AU2003274963A1 (en) | Mda-7 and free radicals in the treatment of cancer | |
| AU2003206945A1 (en) | Use of proteinase inhibitors in the treatment of autoimmune diseases | |
| IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
| AU2003287802A1 (en) | Palpometer and methods of use thereof | |
| AU2003250831A1 (en) | Use of hec1 antagonists in the treatment of proliferative disorders and cancer | |
| AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
| AU2003245858A1 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
| AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
| AU2003270350A1 (en) | Isoxazoles and their use in the treatment of ischemic diseases | |
| AU2003293500A1 (en) | Lactoferrin in the reduction of pain | |
| AU2003219664A1 (en) | Methods and therapeutic compositions in the treatment of advanced cancer | |
| AU2003208289A1 (en) | Deuterated spirocyclopentanimidazolinones and the use thereof in the treatment of cardiovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |